Fakta om udbudet

EU-nr

2015/S 250-457752

Offentliggjort

28.12.2015

Udbyder

University of Copenhagen

Pipettes

University of Copenhagen

Voluntary ex ante transparency notice

This notice is covered by: Directive 2004/18/EC

Section I: Contracting authority/entity

I.1) Name, addresses and contact point(s)

University of Copenhagen
Nørregade 10
For the attention of: Line Kolle
1017 København K
DENMARK
Telephone: +45 35334470
E-mail: line.kolle@adm.ku.dk

Internet address(es):

General address of the contracting authority/entity: http://www.indkoeb.ku.dk

I.2) Type of the contracting authority

Body governed by public law

I.3) Main activity

Other: university

1.4) Contract award on behalf of other contracting authorities/entities

The contracting authority/entity is purchasing on behalf of other contracting authorities/entities: no

Section II: Object of the contract

II.1) Description

II.1.1) Title attributed to the contract

Acquisition of an Agilent Bravo to Clinical Proteomics.

II.1.2) Type of contract and location of works, place of delivery or of performance

Supplies
Purchase

NUTS code DK01

II.1.3) Information about a framework agreement or a dynamic purchasing system (DPS)

II.1.4) Short description of the contract or purchase(s)

Clinical proteomics, a newly established group at CPR, is led by Professor and Program Director Matthias Mann — an international expert in proteomics technology. The newly established clinical proteomics group is about to undertake an ambitious new biomedical research programme involving proteomics of blood/plasma for patient phenotyping.

II.1.5) Common procurement vocabulary (CPV)

38437100

II.6) Information about Government Procurement Agreement (GPA)

The contract is covered by the Government Procurement Agreement (GPA): yes

II.2) Total final value of contract(s)

II.2.1) Total final value of contract(s)

Value: 602 769,82 DKK
Excluding VAT

Section IV: Procedure

IV.1) Type of procedure

Award of a contract without prior publication of a contract notice in the Official Journal of the European Union (in the cases listed in Section 2 of Annexes D1, D2 or D3 as appropriate)
Justification for the choice of the negotiated procedure without prior publication of a contract notice in the OJEU in accordance with Directive 2004/18/EC
The products involved are manufactured purely for the purpose of research, experiment, study or development under the conditions stated in the Directive: yes
The works/goods/services can be provided only by a particular tenderer for reasons that are: technical
Other justification for the award of the contract without prior publication of a contract notice in the OJEU
The contract falls outside the scope of application of the Directive
According to the European Parliament and Council Directive No. 2004/18 / EC, Article 31. 1, point b, the University of Copenhagen believes that the Agilent Bravo is a pipetting robot which enable us a high-throughput processing of clinical samples. We already have established our special plasma proteomic sample preparation workflow on an Agilent Bravo instrument in Munich. This pipetting robot owns unique features like high pipetting accuracy, disposable pipetting tips, the possibility of handling small volumes down to 0.5 µl, it avoids cross-contaminations of the samples (which is crucial to clinical samples), full-automation of our special proteomic work-flow (because it contains different kinds of workstations within one instrument like a Peltier element, heating/shaking positions, place for more than 1000 disposable pipetting tips, a gripper, 9 different workplaces). Moreover, it allows us the parallel preparation of 100 samples in a very short time by the compact design and the high processing speed. This instrument also fulfils necessary criteria for a real clinical application. This combination of features is necessary for our clinical proteomic work-flow and is unique for a pipetting robot. Moreover, Agilent Bravo offers us a discount of nearly 40 % for this product. We already established our special work-flow on an Agilent Bravo instrument in Munich and will transfer this technology now to the Clinical Proteomics group in Copenhagen, which allows us the processing of hundreds of samples in a very reproducible way. We will use the Agilent Bravo pipetting robot on a daily basis for several years. The Agilent Bravo is a pipetting robot which enable us a high-throughput processing of clinical samples. This pipetting robot owns unique features like high pipetting accuracy, disposable pipetting tips, handling of small liquid volumes, no cross-contaminations of samples, automation of our special proteomic work-flow, which allow us the processing of clinical samples like plasma, blood and saliva.

IV.2) Award criteria

IV.2.1) Award criteria

IV.2.2) Information about electronic auction

An electronic auction will be used: no

IV.3) Administrative information

IV.3.1) File reference number attributed by the contracting authority/entity

043-0181/15-7000

IV.3.2) Previous publication(s) concerning the same contract

Section V: Award of contract

V.1) Date of contract award decision:

V.2) Information about offers

V.3) Name and address of economic operator in favour of whom the contract award decision has been taken

Agilent Technologies
Produktionsvej 42
2600 Glostrup
DENMARK
E-mail: ines.nielsen@agilent.com
Telephone: +45 70137313

V.4) Information on value of contract

V.5) Information about subcontracting

The contract is likely to be sub-contracted: no

Section VI: Complementary information

VI.1) Information about European Union funds

The contract is related to a project and/or programme financed by European Union funds: no

VI.2) Additional information:

VI.3) Procedures for appeal

VI.3.1) Body responsible for appeal procedures

Klagenævnet for udbud
Dahlerups Pakhus, Langelinie Allé 17
2100 København Ø
DENMARK
E-mail: klfu@erst.dk
Telephone: +45 35291000
Internet address: http://www.klfu.dk

VI.3.2) Lodging of appeals

Precise information on deadline(s) for lodging appeals A complaint against the contracting entity who, in accordance with the European Parliament and Council Directive No. 2004/18/EC, Article 31, has decided to award a contract without prior publication of a contract notice in the Official Journal of the European Union must,in accordance with the Danish act on enforcement of procurement rules, etc. § 7, para. 3, be filed to the Danish Public procurement Appeal Board within 30 calendar days from the day following the day on which a contract notice is published in the Official Journal of the European Union.
The Danish act on enforcement of procurement rules, etc. defines in § 3, para. 1, point 1, a standstill period of 10 calendar days from the day after the date on which the voluntary ex ante transparency notice is published in the Official Journal of the European Union.
Latest at the same time as a complaint is lodged to the Danish Public procurement Appeal Board, the appellant shall in writing inform the contracting entity about the lodging of a complaint to the Danish Public procurement Appeal Board, and whether the complaint has been submitted in the stand still period. In cases where the complaint is not submitted in the stand still period, the appellant must specify any suspensive effect of the complaint according to The Danish act on enforcement of procurement rules § 12, Para. 1.

VI.3.3) Service from which information about the lodging of appeals may be obtained

Konkurrence- og Forbrugerstyrelsen
Carl Jacobsens Vej 35
2500 Valby
DENMARK
E-mail: kfst@kfst.dk
Telephone: +45 41715000
Internet address: http://www.kfst.dk

VI.4) Date of dispatch of this notice:

23.12.2015